SCRIFFIGNANO, Silvia
 Distribuzione geografica
Continente #
NA - Nord America 735
EU - Europa 642
AS - Asia 102
AF - Africa 96
SA - Sud America 6
Totale 1.581
Nazione #
US - Stati Uniti d'America 731
IE - Irlanda 324
CI - Costa d'Avorio 96
FI - Finlandia 72
CN - Cina 54
UA - Ucraina 51
DE - Germania 47
SG - Singapore 37
IT - Italia 36
AT - Austria 26
SE - Svezia 25
FR - Francia 22
GB - Regno Unito 22
BE - Belgio 6
BR - Brasile 6
RU - Federazione Russa 6
IN - India 5
CA - Canada 4
CZ - Repubblica Ceca 2
TR - Turchia 2
BD - Bangladesh 1
ES - Italia 1
KZ - Kazakistan 1
MY - Malesia 1
NO - Norvegia 1
PH - Filippine 1
PL - Polonia 1
Totale 1.581
Città #
Dublin 324
Chandler 184
Jacksonville 112
Abidjan 96
Helsinki 70
Ann Arbor 45
Vienna 26
Singapore 25
Wilmington 24
Princeton 23
San Mateo 23
Ashburn 22
Boardman 19
Dearborn 19
Beijing 17
Rome 15
Redwood City 11
Los Angeles 9
Manchester 8
Woodbridge 8
Nanjing 7
New York 7
Brussels 6
Esslingen am Neckar 5
Fleet 4
Guangzhou 4
Ariccia 3
Borås 3
Frankfurt am Main 3
Hefei 3
Ningbo 3
Tianjin 3
Avignon 2
Cernusco sul Naviglio 2
Changsha 2
Eden Prairie 2
Houston 2
Ilmenau 2
Jinan 2
João Pessoa 2
Lappeenranta 2
Letchworth Garden City 2
Mountain View 2
Olomouc 2
Quzhou 2
San Bernardino 2
Shanghai 2
Shenyang 2
Simi Valley 2
Stockport 2
Zhengzhou 2
Almaty 1
Auburn 1
Bangalore 1
Baotou 1
Campobasso 1
Carpi 1
Dhaka 1
Falkenstein 1
Forest City 1
Gravina di Catania 1
Grottaglie 1
Hyderabad 1
Jaipur 1
Kharkov 1
Kuala Lumpur 1
Kunming 1
Lanzhou 1
Leawood 1
London 1
Manila 1
Milan 1
Norwalk 1
Novokuznetsk 1
Oakville 1
Oslo 1
Paris 1
Paternò 1
Phoenix 1
Pointe-Claire 1
Rockville 1
San Francisco 1
Seattle 1
Tappahannock 1
Teresopolis 1
Toronto 1
Warsaw 1
Totale 1.205
Nome #
Analysis of potential determinants for a treat-to-target strategy in psoriatic arthritis patients from a real-world setting 102
Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients 87
Residual disease activity in rheumatoid arthritis patients treated with subcutaneous biologic drugs that achieved remission or low disease activity: a longitudinal observational study 82
Mesenchimal stem cells: A possible role in the pathogenesis and treatment of spondyloarthritis 76
Validation of the Italian version of proposed GRAPPA flare questionnaire for patients with psoriatic arthritis 75
From clinical remission to residual disease activity in spondyloarthritis and its potential treatment implications 74
An Assessment of Hand Erosive Osteoarthritis: Correlation of Radiographic Severity with Clinical, Functional and Laboratory Findings 73
Multimorbidity and comorbidity in psoriatic arthritis–a perspective 65
Role of comorbidities in spondyloarthritis including psoriatic arthritis 62
Assessment of bone morphogenic protein 2 and interleukine-17A in patients with axial spondyloarthritis and their potential role in the new bone formation: a cross-sectional study 60
Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: Association with disease activity and quality of life indices 60
Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study 52
Psoriatic arthritis, psoriatic disease, or psoriatic syndrome? 52
Case report of polymyalgia rheumatica in a male patient with three different neoplasms treated with pembrolizumab 52
Impact of Comorbidities on Disease Activity, Patient Global Assessment, and Function in Psoriatic Arthritis: A Cross-Sectional Study 52
Occult axial involvement in patients with psoriatic arthritis mutilans: a case report 49
Assessment of widespread and extra-articular pain in psoriatic arthritis: a case-control study 48
Dr. Lubrano, et al reply 47
TNF-alpha inhibitors for the six treatment targets of psoriatic arthritis 43
Residual disease activity and associated factors in Psoriatic Arthritis 42
Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study 35
Rheumatology Care in the Face of COVID-19 35
SARS-CoV-2 IgM False-Positivity in a Psoriatic Arthritis Patient Seropositive for Rheumatoid Factor and ACPA: An Interference of Immune Response? 28
MRI Assessment of Extra-axial Findings at Pelvic Sites in a Group of Axial-SpA Patients 28
Clinical Characteristics of Potential "Difficult-to-treat" Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort 26
Dactylitis and Early Onset Psoriasis in Psoriatic Arthritis: Are they Markers of Disease Severity? A Clinical Study 25
Psoriatic Arthritis in Males and Females: Differences and Similarities 24
The "Climb" Towards Minimal Disease Activity in Psoriatic Arthritis 23
Constrictive Pericarditis With Massive Calcification in Systemic Sclerosis Treated With Pericardiectomy: A Case Report 22
Therapeutic Targets for Ankylosing Spondylitis - Recent Insights and Future Prospects 21
New Insights in Physical Therapy and Rehabilitation in Psoriatic Arthritis: A Review 21
Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective 21
Cardiovascular comorbidities in psoriatic arthritis: epidemiology and risk factors in two different European populations 17
Ultrasonographic Evaluation of Entheseal Fibrocartilage in Patients with Psoriatic Arthritis, Athletes and Healthy Controls: A Comparison Study 13
Patient reported outcomes in early vs late diagnosis of psoriatic arthritis|Resultados informados por los pacientes en el diagnóstico precoz respecto a los pacientes con diagnóstico tardío en la artritis psoriásica 11
Triple jump for the optimal management of psoriatic arthritis: Diet, sleep and exercise - A review 9
Clinical Characteristics of "Severe" Peripheral Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort 7
Assessment of Patient-Physician Interactions in Psoriatic Arthritis: National Results of the ASSIST Study 5
Sensitivity and Specificity of Composite Indices of Remission in Male and Female Patients With Psoriatic Arthritis: A Multicenter Cross-Sectional Study of Longitudinal Cohorts 5
A strategy towards disentangling treatment refractory from misdiagnosed axial Spondyloarthritis 5
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis 4
Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis 3
Multifocal fibrosclerosis in a patient with HIV infection treated with rituximab 3
Totale 1.644
Categoria #
all - tutte 9.546
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.546


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020163 4 0 10 17 11 4 48 15 17 17 4 16
2020/2021186 7 18 0 29 31 9 29 10 23 6 24 0
2021/2022116 7 23 0 3 4 0 2 11 21 32 2 11
2022/2023752 88 30 16 58 18 50 8 40 379 37 19 9
2023/2024243 59 40 24 5 12 13 2 21 9 13 15 30
2024/2025109 109 0 0 0 0 0 0 0 0 0 0 0
Totale 1.644